International Clinical Trial: Anrikefon Injection for Postoperative Analgesia in Thoracoscopic Lung Surgery: A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Single-Center Clinical Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810413) titled 'Anrikefon Injection for Postoperative Analgesia in Thoracoscopic Lung Surgery: A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Single-Center Clinical Study' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: The First People's Hospital of Lianyungang

Condition: Postoperative Pain

Intervention: Drug: Anrikefon Injection

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September ...